- Report
- December 2023
- 331 Pages
Global
From €4632EUR$4,799USD£3,973GBP
- Report
- August 2023
- 1500 Pages
Global
From €8445EUR$8,750USD£7,245GBP
- Report
- September 2023
- 141 Pages
Global
From €1737EUR$1,800USD£1,490GBP
€2172EUR$2,250USD£1,863GBP
- Report
- January 2024
- 120 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- January 2024
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- May 2023
- 142 Pages
Global
From €2412EUR$2,499USD£2,069GBP
- Report
- March 2024
- 200 Pages
Global
From €4006EUR$4,150USD£3,436GBP
- Report
- February 2024
- 209 Pages
Europe
From €4006EUR$4,150USD£3,436GBP
- Report
- February 2024
- 72 Pages
South Korea
From €4826EUR$5,000USD£4,140GBP
- Report
- January 2023
- 195 Pages
Latin America
From €4826EUR$5,000USD£4,140GBP
- Report
- October 2022
- 348 Pages
Indonesia, Malaysia, Singapore Indonesia, Malaysia, Singapore
From €4826EUR$5,000USD£4,140GBP
- Report
- October 2022
- 220 Pages
United States
From €4826EUR$5,000USD£4,140GBP
- Report
- June 2022
- 55 Pages
India
From €4826EUR$5,000USD£4,140GBP
- Report
- March 2022
- 312 Pages
Global
From €6756EUR$7,000USD£5,796GBP
- Report
- September 2021
- 144 Pages
China
From €3861EUR$4,000USD£3,312GBP
- Report
- June 2021
- 197 Pages
Latin America
From €3861EUR$4,000USD£3,312GBP
- Report
- March 2021
- 196 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- October 2019
- 214 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- February 2024
- 218 Pages
Japan
From €1824EUR$1,890USD£1,565GBP
- Report
- April 2021
- 302 Pages
Global
From €1327EUR$1,375USD£1,138GBP
€2654EUR$2,750USD£2,277GBP
The Tumor Marker market is a segment of the In Vitro Diagnostics (IVD) industry. It is composed of products used to detect the presence of cancer in a patient. These products are typically used to diagnose, monitor, and assess the effectiveness of cancer treatments. Tumor markers are typically proteins, hormones, or other substances that are produced by cancer cells or by the body in response to cancer. They can be detected in the blood, urine, or other body fluids.
The Tumor Marker market is a rapidly growing segment of the IVD industry, driven by the increasing prevalence of cancer and the need for early diagnosis and effective treatment. The market is expected to continue to grow in the coming years, driven by technological advancements and the development of new products.
Some of the major companies in the Tumor Marker market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more